Practical research skills Flashcards
Order of research
Research question
Study design
Research methods
Data collection tools
Data analysis
Dissemination
PICOST
Population
Intervention or Exposure
Control
Outcome
Setting
Timing or study Type
SMART
Specific
Measurable
Achievable
Realistic
Timely
Types of observational studies
Cross sectional
Cohort
Case control
Cross sectional study definition and considerations
Snapshot at a single point in time, with exposure and disease assessed simulataneously
Faster and less expensive than cohort studies
Cannot determine time relation between exposure and outcome
Cohort study description and considerations
Population of exposed vs unexposed followed up prospectively over a period of time to look for development of the outcome
Good for rare exposures and can assess multiple outcomes
Challenging if rare outcome or long latency
Very resource intensive
Case control study description and considerations
Participants recruited based on the presence or absence of an outcome then assessed retrospectively
Can assess for multiple exposures
Relatively fast
Risk of recall bias and controls must be chosen caefully
Three principles of confounders
- Associated with the exposure
- Risk factor for the outcome
- Not on the causal pathway between the exposure and outcome
Four options for dealing with confounders
e.g. ice cream , time spent at beach, shark attack example
- Restricting - only recruit those who spend time at the beach
- Matching - match participants based on the amount of time they spend at the beach
- Statistical control - Incorporate time spent at the beach as a variable in the statistical analysis
- Randomisation
Examples of bias
- Selection bias - study population does not represent the whole population of interest, comparison groups are not comparable
- Information bias - any error in the measurement of exposure or the outcome means there are systematic differences in the accuracy of information collected
e.g. recall bias
Clinical trial - four examples of “interventions”
Preventative strategy
Treatment
Screening tool
Diagnostic test
Phase 1 of a clinical trial
SAFE
Pharmacokinetics/pharmacodynamics in healthy volunteers
Small sample
Phase 2 of a clinical trial
EFFICACY
How well does the treatment work
Bigger sample than phase 1
May recruit participants who have not responded to standard treatments
Phase 3 clinical trial
IMPACT
Is the new treatment better than existing treatments?
Including
QOL
Reduction in the risk of recurrence
Side effect profile
Cost
Acceptability/feasibility
Phase 4 clinical trial
Is there a better way of implementing this treatment?
e.g. dose reduction, optimal length of treatment…
Cluster randomised study design
Larger groups (clusters) are randomised rather than individuals
Used when an intervention may affect a whole group leading to “contamination”
e.g. Asssessing the rate of smear test uptake after displaying posters about cervical cancer in a GP surgery
Blind study design
Do not know which intervention the participants receive
Single - only participants unaware
Double - both participants and investigators unaware
Crossover study design
Participants receive multiple treatments in a specific sequence, with each participant serving as their own control
May be useful if one particular treatment is known to be effective and you want everyone to have the opportunity to have it
Factorial study design
Evaluates multiple interventions simultaneously by using different combinations of treatments. This allows the study to assess both individual and interaction effects of the treatments
Adaptive study design
Allows modifications to the trial and/or
statistical procedures of the trial after its initiation without
undermining its validity and integrity to make clinical trials more
flexible, efficient and fast. Eg MAMS (multi-arm, multi-stage)
Superiority trial
Is the new treatment is better than the existing one
Equivalence trial
Equivalence - there is no difference between the new treatment and the existing one (clinical equivalence vs bioequivalence)
Non-inferiority trial
The new drug is not worse than the existing treatment by more
than a specified margin [the non-inferiority margin (δ)]
Any difference between two groups can occur as a result of….
Bias - reduced by randomisation
Confounding - addressed by randomisation
Chance - addressed by sample size calculations
A true difference in outcome